PRIMARY STUDY
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Key Findings: The study demonstrated up-regulation of the CB1 receptor in direct response to neuronal injury in a human PD cell culture model, and a direct neuronal protective effect of Δ⁹-THC that may be mediated through PPARγ activation.
Type of Study: Laboratory Study
Study Result: Positive
Cannabinoids Studied: Tetrahydrocannabinol (THC), AM-x Synthetic Cannabinoids, WIN-x Synthetic Cannabinoids
Phytocannabinoid Source: Not Applicable
Chemotype: Chemotype I
Form of Administration: Not Applicable
Receptors Studied: PPAR - Gamma
Study Location(s): United Kingdom
Year of Pub: 2012
Link to study